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Treatment efﬁcacyIt is recognized that the clinical efﬁcacy of single dose benzimidazoles (BZs) against the nematode, Trichu-
ris suis of pigs and the closely related Trichuris trichiura in humans is only poor to moderate. Recent
in vitro studies have indicated that a low uptake of fenbendazole (FBZ) in T. suis may be responsible
for its poor efﬁcacy. The aim of this study was to investigate this hypothesis by measuring the concen-
trations of FBZ and its metabolites, oxfendazole (OXF) and FBZ sulphone (FBZSO2), in T. suis isolated from
FBZ treated pigs and in plasma of the pigs. The highest concentration of FBZ measured in T. suis was
66.6 pmol/mg dry worm tissue which was approximately half of what was measured in a previous
in vitro study. The correlation between drug concentrations in plasma and in T. suis worms was highly
positive for OXF (r = 0.93, P = 0.0007) and FBZSO2 (r = 0.85, P = 0.007), but no correlation was found for
FBZ. This study shows that the low uptake of FBZ observed for T. suis in vitro, also takes place in vivo.
The high and signiﬁcant correlations between OXF and FBZSO2 concentrations in plasma of the pigs
and T. suis (and the lack of this correlation for FBZ) suggests that the metabolites reach the worms via
the blood–enterocyte interface while FBZ primarily reaches the worms via the intestinal lumen of the
host.
 2014 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The whipworm Trichuris trichiura has been estimated to infect
464.6 million people worldwide resulting in an estimated 0.64 mil-
lion disability adjusted life-years lost globally (Pullan et al., 2014).
The anthelmintic drug regimens recommended by the World
Health Organization (WHO) against human trichuriasis are a sin-
gle-dose treatment with albendazole (ALB) or mebendazole
(MBD) (WHO, 2013), which have shown only low to moderate cure
rates (Keiser and Utzinger, 2008; Olsen et al., 2009; Knopp et al.,
2010; Steinmann et al., 2011; Namwanje et al., 2011). Fenbendaz-
ole (FBZ), another BZ is widely used against gastrointestinal nem-
atodes of veterinary importance, amongst these the whipworm of
the pig, Trichuris suis. The current treatment recommendation of
T. suis infection with FBZ is a single dose of 25 mg/kg, according
to the Danish Health and Medicine Authority (2013), which is 5
times higher than recommended for other common gastrointesti-
nal nematodes of the pig, e.g., Ascaris suum and Oesophagostomum
spp. The dose of 5 mg/kg has resulted in a worm count reduction
(WCR) of 93.1%, whereas a dose of 25 mg/kg reduced worm counts
by 97.4% (Batte, 1978). A high efﬁcacy has been reported when5 mg/kg was used for 3 consecutive days resulting in a WCR of
99.7% and 99.9% four and ﬁve days after the last treatment day
(Batte, 1978; Stewart et al., 1981). Treatment recommendations
for another BZ, ﬂubendazole, is a standard dose (5 mg/kg) divided
over 7 days, which indicate that long term treatments of T. suis
infections is a premise for achieving adequate drug efﬁcacy
(Taylor, 1999).
Efﬁcacy of an anthelmintic is dependent on the ability of the
active compound to reach the location of the parasite and to enter
and bind to speciﬁc receptors within the parasite in sufﬁcient and
sustained concentrations (Alvarez et al., 2007). For BZs, the recep-
tor is the b-tubulin in nematodes (Lacey, 1988). The fate of the drug
in the host therefore plays a crucial role for in drug concentration
and duration of exposure at the target site. FBZ is oxidised to the
pharmacological active oxfendazole (OXF) and the less active fen-
bendazole sulphone (FBZSO2) in a range of mammals, ﬁsh and
birds (Short et al., 1988).
Previous in vitro studies on motility and drug uptake of T. suis
andOesophagostomum dentatum (the nodularworm of the pig) have
shown a lower pharmacological effect on T. suis than O. dentatum
when exposed to FBZ (Hansen et al., 2014). We hypothesized that
a low drug-uptake of FBZ in T. suis in vitro was responsible for this
effect. Themain objective of this studywas therefore to conﬁrm this
hypothesis bymeasuring the concentrations of FBZ andmetabolites
within T. suis worms isolated from FBZ treated pigs.
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2.1. Experimental animals
Fourteen castrated male pigs (25 kg) were purchased from a
Speciﬁc Pathogen Free (SPF) farm (Frenderupgård, Sorø, DK) with
no history of helminth infections for 10 years. Pigs were acclima-
tized 1 week prior to experimental infection. The pigs were identi-
ﬁed by ear tags and tested for current gastrointestinal parasite
infections on the day of arrival and on the day of infection by
means of a modiﬁed McMaster method (Roepstorff and Nansen,
1998). The animals had free access to water and were fed restric-
tively with a diet consisting of 75% barley and 25% supplementary
feed (NAG, Helsinge, DK). Due to risk of coprophagia the two con-
trol pigs (no drug treatment) were kept separately.
2.2. Ethic statement
The current study was approved by the Experimental Animal
Unit, University of Copenhagen, (Denmark) based on national reg-
ulations from the Danish Animal Experiments Inspectorate (per-
mission No. 2010/561-1914, C5).
2.3. Experimental design
All animals were inoculated with 5000 embryonated T. suis
eggs (kindly provided by Parasite Technologies A/S, DK) using a
stomach tube. Infection was conﬁrmed in all pigs by a modiﬁed
McMaster method at day 48 post inoculation (p.i.), and on the ﬁrst
treatment day (day 49 p.i.). After stratiﬁcation for faecal egg count
(FEC) (49 day p.i.), pigs were randomly allocated into 4 treatment
groups with 3 animals in each (Table 1). The remaining two pigs
served as control group. On day 49 p.i. the pigs in group 1 and 2
were given FBZ (Panacur 4% oral powder as an aqueous suspen-
sion) through a stomach tube at a dose rate of 5 mg/kg, whereas
the pigs in group 3 and 4 were given 5 mg/kg daily for 3 days.
The pigs in group 1 and 2 were euthanized 12 and 24 h after the
ﬁrst treatment, respectively, whereas the pigs in group 3 and 4
were euthanized 12 and 24 h after the third treatment, respec-
tively. These time points were chosen match the in vitro study
where worms were incubated for 24 and 72 h, respectively, and
to obtain information about the dynamics of the uptake after a sin-
gle and triple treatments. Two heparinized blood samples were
collected from venae jugularis from all pigs just prior to euthana-
sia. Blood samples were centrifuged at 2000g for 15 min and
recovered plasma stored at 20 C until HPLC analysis. The two
control animals were euthanized at the same time as the animals
in group 4. All pigs were euthanized by captive bolt pistol followed
by exsanguination.
2.4. Worm recovery
The pigs were immediately eviscerated and the caecum and
large intestines separated from the stomach and the small intestine.
The caecum and the large intestine were divided into 4 sectionsTable 1
Mean (±SD) faecal egg counts (FEC) in the treated groups and control group on day 49
post inoculated (p.i.) with a single dose of 5000 embryonated Trichuris suis eggs.
Groups Mean FEC 49 days p.i. (egg per gram of faeces)
Control (n = 2) 1890 ± 834
Group 1 (n = 3) 4553 ± 3855
Group 2 (n = 3) 2880 ± 3248
Group 3 (n = 3) 4527 ± 3012
Group 4 (n = 3) 3853 ± 3707
No signiﬁcant difference was found between group means (P = 0.87).starting at the caecum. Section 1: caecum; section 2: 0–25% of the
total length of the colon, section 3: 26–50% of the total length of
the colon; section 4: 51–100% of the total length of the colon includ-
ing rectum. All sections were opened and gently liberated from
intestinal content, which was kept for later worm count, and rinsed
brieﬂy in 39 C saline. The adult worms were gently collected from
the intestinal wall by hand, counted and washed in 50 mL 39 C sal-
ine for a maximum of 30 s by carefully inverting the 50 mL centri-
fuge tubes. From each pig, 3 times 30 worms were collected from
caecum; if the number of wormswas insufﬁcientmorewormswere
included distally in colon, i.e., from sections 2, 3 or 4 in the men-
tioned order. If no worms were observed attached to the mucosa,
worms were isolated from the intestinal content. After washing
the worms were poured into petri dishes in approximately 0.5 mL
of saline from where the worms were gently transferred to Eppen-
dorf tubes with a curved forceps. Excess water in the Eppendorf
tubes was removed using a pipette and the worms frozen in liquid
nitrogen. All samples were kept at 20 C until HPLC analysis.
2.5. High-performance liquid chromatography analysis (HPLC)
FBZ and it metabolites in worms and plasma were measured
using the HPLC method described for plasma by Petersen and
Friis (2000) with minor modiﬁcations. Vials with worms were
thawed and then dried under phosphorous pentoxide until con-
stant weight. Each vial with dried worm (10–50 mg, equivalent
to 18–30 worms) was mixed with 200 ll 0.05 M phosphate buffer
(pH 7.4). After gentle homogenization with plastic pestle another
200 ll buffer was added and the homogenization repeated before
addition of 400 ll 6 M guanidine HCl. The sample was mixed on
a vortex mixer for 1 min and placed at 20 C for 15 min before cen-
trifugation at 8000g for 10 min. The supernatant was transferred
to a clean tube and an additional 400 ll of 6 M guanidine HCl was
added to the sample residue. The procedure was repeated and the
two supernatants were combined and loaded on an activated car-
tridge (Oasis HLB, 60 mg, 3 mL). The cartridge was activated with
2 mL methanol followed by 2 mL of water. The loaded cartridge
was washed with 2 mL 5% methanol and allowed to dry under vac-
uum for 1 min, before eluting the analyte with 2 mL methanol. The
eluate was dried at 37 C and the residuumwas dissolved in 100 lL
50% methanol. This solution was centrifuged at 8000g before
50 lL were injected into the HPLC-system. A blank worm sample
and standards in phosphate buffer and guanidine HCl were run
in parallel. Standards of FBZ, OXF and FBZSO2 were prepared from
stock solutions in DMSO. Concentration of analyte in worms was
expressed as pmol/mg dry worm tissue. Plasma samples were pre-
pared for HPLC analyses by using Oasis HLB cartridge as described
above. Instead of guanidine HCl solution 1 mL of plasma was
loaded on the activated cartridge. The rest of the cleaning up pro-
cedure was as described above. The HPLC system (Waters) was
equipped with an auto sampler, 2 HPLC pumps, and a UV detector
set at 294 nm. Separation of analytes was accomplished at 30 C on
a Novapak C18 (5 l, 15 cm). The mobile phase consisted of a gradi-
ent mixed from acetonitrile and 0.025 M ammonium acetate (pH
7.2) at a ﬂow rate of 1 mL/min. The proportion of acetonitrile
was 30% acetonitrile for the ﬁrst 3 min, progressing linearly to
40% at 3.5 min, held constant at 40% until 11 min and ﬁnally
reduced to 30% at 11.5 min for the remaining run time of 17 min.
Retention times for FBZ, OXF and FBZSO2 were 13 min, 2.5 min
and 4.5 min, respectively. Peak area of an analyte was used to cal-
culate concentration of the analyte. The method for detecting FBZ,
OXF and FBZSO2 in worms (buffer-guanidine suspension) was val-
idated in-house by evaluating the following parameters: linear
range, recovery, matrix effect, precision, selectivity and limit of
quantiﬁcation. As described above the dry worms were suspended
in buffer-guanidine and the validation was conducted based on the
Table 2
Number of Trichuris suis in 14 pigs and worm count reductions 12 and 24 h after 1 or 3 times treatment with FBZ (5 mg/kg), respectively.
Control Group 1 Group 2 Group 3 Group 4
12 h after 1  5 mg/kg 24 h after 1  5 mg/kg 12 h after 3  5 mg/kg 24 h after 3  5 mg/kg
(n = 2) (n = 3) (n = 3) (n = 3) (n = 3)
Worm count 1092 78 839 161 1
3393 3615 386 202 200
3982 2512 523 122
Geometric mean 1925 1039 934 257 29
Worm count reduction (%) n.a. 46.0 51.5 86.6 98.5
Group 1: 12 h after 1 dose of FBZ; group 2: 24 h after 1 dose of FBZ; group 3: 12 h after 3 doses of FBZ; group 4: 24 h after 3 doses of FBZ.
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for FBZ were linear between 0.1 and 1 lg loaded on the SPE and for
OXF and FBZSO2 between 0.05 and 0.5 lg loaded on SPE. The recov-
ery of FBZ, OXF and FBZSO2 was determined by comparing the
responses of matrix standards in the range from 0.05 to 1 l loaded
on SPE with water standards in the same concentrations. The
recovery was 76%, 101% and 75% for FBZ, OXF and FBZSO2, respec-
tively. No matrix effect could be demonstrated. The intra-assay and
inter-assay variability were 10% and 12%, respectively. The limit of
quantiﬁcation (LOQ) was 1.5, 0.5 and 0.8 lg/mg dry worm for FBZ,
OXF and FBZSO2, respectively corresponding to 5.3, 1.7 and
2.4 pmol/mg dry worm tissue.
2.6. Worm count reduction (WCR)
For each pig any remaining worms attached to the mucosa were
collected and mixed with the intestinal contents from caecum and
the large intestine. Each sample was then mixed thoroughly and a
10% subsample was washed on a 212 lM sieve and the collected
material stained with iodine and stored for later counting. Due to
low numbers of pigs in each treatment group and the early time
of treatment evaluation, worm counts were only used to get indic-
ative information on the treatment efﬁciency. Worm count reduc-
tion was calculated as follows:
Percentage WCR ð%Þ ¼ X

g ðcontrol pigsÞ  X

g ðtreated pigsÞ
X

g ðcontrol pigsÞ
 100
where X

g is the geometric mean number of parasites (Hennessy
et al., 2006).Table 3
Mean concentrations (±SD) of FBZ, OXF and FBZSO2 in plasma and in Trichuris suis 12 and 2
groups 2: 24 h after 1 dose of FBZ; group 3: 12 h after 3 doses of FBZ; group 4: 24 h after
n = number of animals Mean concentration in plasma (pmol/mL) n = numb
FBZ OXF FBZSO2 Total
Control (n = 2) 0 0 0 0 Control (n
Group 1
(n = 3)
12 h
269.31
(±97.20)
(7.0)
2491.16
(±690.77)
(64.7)
1090.15
(±421.54)
(28.3)
3850.62
(100)
Group 1
(n = 2)
Group 2
(n = 3)
24 h
125.51
(±89.94)
(2.8)
2610.68
(±720.86)
(57.9)
1774.78
(±470.84)
(39.3)
4510.97
(100)
Group 2
(n = 2)
Group 3
(n = 3)
12 h
434.64
(±210.43)
(4.5)
5743.10
(±1707.80)
(59.5)
3476.55
(±533.06)
(36.0)
9654.29
(100)
Group 3
(n = 2)
Group 4
(n = 3)
24 h
237.25
(±53.76)
(2.9)
4030.95
(±342.70)
(48.9)
3974.11
(±1416.90)
(48.2)
8242.31
(100)
Group 4
(n = 2)
Total mean 235.0
(3.8)
3432
(55.1)
2558.1
(41.1)
6225
(100)
Total mea
Each worm sample consisted of triplets except one where only a single subsample was o
by different superscripts (a and b). Signiﬁcant differences between groups (vertically) are
4). Numbers in italic and brackets are relative concentrations (%) in plasma of the pig a2.7. Statistical analysis
One-way analysis of Variance (ANOVA) (JMP version 8) was used
to test for similar FEC distribution between treatment groups. For
each group, ANOVA and Student’s t-test (JMP version 8) was used
to compare log-transformed drug concentrations (log_conc) of FBZ,
OXF and FBZSO2 measured within worms. Student’s t-test was used
to compare log-concentrations of each drug compound in worms 12
and 24 h after a single and triple dose treatment, respectively. Pear-
son correlation coefﬁcient (r) was calculated using GraphPad Prism
(version 6) to examine the relationship between drug concentrations
measured in the worms and in the plasma of the pig.3. Results
3.1. Establishment of infections and worm counts
Patent infections were observed in all pigs day 49 p.i. and no
signiﬁcant differences were found between group mean FEC
(P = 0.87) (Table 1). Individual worm counts and worm count
reductions are shown in Table 2. Based on the two control animals
the establishment rate was 39%. Fenbendazole showed an immedi-
ate effect on worm counts with reductions of respectively, 46% and
51.5% as soon as 12 and 24 h after the ﬁrst treatment (Table 2).
Fenbendazole given for 3 consecutive days resulted in WCR of
86.6% and 98.5% 12 and 24 h after the last treatment, respectively.
3.2. Drug concentrations in plasma and worms
After a single oral administration total drug concentration in
plasma (FBZ plus metabolites) was 3851 pmol/mL at 12 h and4 h after 1 or 3 times treatment with FBZ (5 mg/kg). Group 1: 12 h after 1 dose of FBZ;
3 doses of FBZ.
er of worm samples Mean concentration in worms (pmol/mg dry worm tissue)
FBZ OXF FBZSO2 Total
= 2) 0 0 0 0
6.47a,A
(±1.1)
(14.5)
20.72b,A
(±6.53)
(46.3)
17.53b,A
(±3.59)
(39.2)
44.71
(100)
14.57a,C
(±1.4)
(22.7)
16.02a,C
(±10.87)
(25.0)
33.57b,C
(± 5.66)
(52.3)
64.16
(100)
29.3a,B
(±19.27)
(15.8)
56.73a,B
(±1.20)
(30.6)
99.18a,B
(±72.48)
(53.6)
185.21
(100)
66.63a,D
(±1.6)
(39.7)
26.73b,C
(±13.43)
(15.9)
74.67a,C
(±75.09)
(44.4)
168.03
(100)
n 31.7
(27.7)
33.0
(28.8)
49.9
(43.5)
114.4
(100)
btained. Signiﬁcant differences (P < 0.05) within groups (horizontally) are indicated
indicated by different superscripts (A, B for groups 1 and 3 and C, D for groups 2 and
nd T. suis, respectively, measured at each time-point and of the total mean.
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accounting 65% and 58% of total drug at 12 and 24 h, respectively,
followed by FBZSO2 (28%; 39%) and FBZ (7%; 3%) (Table 3).
Repeated administration of FBZ for 3 days resulted in total drug
concentrations of 9654 pmol/mL at 12 h and 8242 pmol/mL at
24 h after the last dose, indicating an accumulation of drug after
repeated dosing. OXF still remained the major compound in
plasma (60% at 12 h and 49% at 24 h), followed by FBZSO2 (36%;
48%) and FBZ (5%; 3%).
In T. suis total concentration of drug was 44.7 pmol/mg dry
worm tissue at 12 h and 64.2 pmol/mg dry worm tissue at 24 h
after single administration. Repeated administration of FBZ for 3
consecutive days resulted in an accumulation of drug and metabo-
lites of 185.2 and 168.0 pmol/mg 12 and 24 h after the last dose.
The distribution pattern of FBZ and its metabolites differ to some
extent between the worms and the host plasma. In T. suis OXF
accounted for the major fraction 12 h after a single dose but 24 h
post administration and after repeated doses, FBZSO2 was domi-
nating Correlations between plasma and worm concentrations of
each drug-metabolite, including all pigs, are shown in Fig. 1. The
correlation analysis revealed that OXF and FBZSO2 concentrations
in the host plasma were highly correlated with the concentrations
in T. suis (r = 0.93, P = 0.0007; r = 0.85, P = 0.007, respectively,
Fig. 1b and c) whereas no correlation was found for FBZ (r = 0.37,
P = 0.36). The concentration of FBZ remained relatively higher in
the worms than in the plasma of the host (Table 3).Fig. 1. Correlation between concentration of (a) -d- FBZ (r = 0.37, P = 0.36), (b) -N-
OXF (r = 0.93, P = 0.0007), and (c) -.- FBZSO2 (r = 0.85, P = 0.007) in plasma of pigs
and in Trichuris suis isolated from these pigs.4. Discussion
The main objective of this study was to measure the concentra-
tion of FBZ and metabolites within T. suis in order to investigate
whether the low drug uptake observed in vitro (Hansen et al.,
2014) could be conﬁrmed in vivo and thereby explain the low phar-
macological effect against this species. Data conﬁrmed that the low
drug uptake of FBZ measured in T. suis in vitro also take place
in vivo. Indeed, the highest concentrations of FBZ measured in T.
suis after single and repeated administration of FBZ for 3 days were
14.6 and 66.6 pmol/mg dry worm tissue, respectively (Table 3).
These concentrations were approximately six and two times lower
than those measured in the worms in vitro after 24 and 72 h expo-
sure to FBZ at a range of 0.01–30 lM (2–88 and 3–120 pmol/mg
dry worm tissue, respectively) (Hansen et al., 2014). It can be
argued that the drug concentrations the worms were exposed to
in vivo are not comparable with the FBZ concentrations used
in vitro. However, in a study by Petersen (1998) single-dose FBZ
(5 mg/kg) was administered to 12 pigs through a stomach tube,
as in this study. The concentration of FBZ in caecum content varied
between 1 and 2.6 lg/g and between 1.5 and 7.1 lg/g in mucosa of
the caecum during the 24 h observation period. The lowest and the
highest values, 1 and 7.1 lg/g wet tissue are equivalents to 3 and
24 lM. It is therefore likely that within 24 h of the ﬁrst treatment,
worms were exposed to concentrations between 0.01 and 30 lM
as used in vitro (Hansen et al., 2014). However, when worms were
exposed to 1 lM FBZ for 24 and 72 h in vitro, FBZ concentrations in
the worms were almost as high (83 and 93 pmol/mg dry worm tis-
sue, respectively) as when exposed to 30 lM (Hansen et al., 2014).
In the present study, pigs were dosed FBZ (5 mg/kg) at an interval
of 24 h for three days, hence, drug concentrations at the predilec-
tion site were expected not to fall below 3 lMduring the last treat-
ment day, but highly likely to increase due to accumulation.
Therefore we conclude that the exposure in vitro and in vivo has
been within the same range and that the uptake of FBZ by T. suis
is even lower in vivo than in vitro.
Adult stages of T. suis inhabit the lower part of the intestine, pri-
marily the caecum and proximal colon (Pedersen and Saeed, 2000;Kringel and Roepstorff, 2006). The anterior oesophageal part of the
worm is embedded in the mucosa in a tunnel like-construction of
epithelial cells, while the posterior thick part is protruding freely
into the lumen (Jenkins, 1970). Consequently, Trichuris spp. may
be exposed to anthelmintic drugs present in both the mucosa
and the digesta of the intestinal lumen which is quite unique for
adults of a nematode species. High correlations between drug con-
centrations of OXF and FBZSO2 in host plasma and worms suggest
that these metabolites enter the worms via the blood–enterocyte
Table 4
Relative (%) and actual concentrations of FBZ, OXF and FBZSO2 in pigs and worms 12 and 24 h after one treatment with FBZ (5 mg/kg).
12 h Total 24 h Total
FBZ OXF FBZSO2 FBZ OXF FBZSO2
Petersen (1998):
Plasma (%)
(pmol/ml)
5.0
67
75.8
(1268)
19.2
(362)
100
(1883)
8.2
(167)
54.6
(1111)
37.1
(754)
100
(2031)
Caecal (%)
mucosa (pmol/g)
58.1
(13028)
36.8
(8245)
5.1
(1132)
100
(22405)
53.0
(4176)
20.1
(1586)
26.8
(2113)
100
(7874)
Caecal (%)
content (pmol/g)
75.7
(8351)
21.6
(2379)
2.7
(302)
100
(11032)
85.7
(3341)
8.1
(317)
6.2
(241)
100
(3899)
Present study (%)
Plasma 7 64.7 28.3 100 2.8 57.9 39.3 100
Worms (in vivo) 14.5 46.3 39.2 100 22.7 25 52.3 100
Hansen et al. (2014)
Worms (in vitro)
– – – – 96 4.0 0 100
Relative concentrations in italics are from the present study. Relative concentrations in bold are from the pharmacokinetic study of FBZ in pigs (Petersen, 1998).
Concentrations of FBZ, OXF and FBZSO2 in brackets are given in pmol/mL (plasma) and pmol/g (Caecal mucosa and Caecum content). Underlined relative concentrations from
a previous in vitro study where Trichuris suis was exposed to 30 lM FBZ (Hansen et al., 2014).
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tions in plasma and worms, may enter the worms both by the
blood–enterocyte pathway and directly from the digesta. As this
study was designed to measure the drug uptake of T. suis in vivo,
no attempts were made to measure the concentrations of FBZ,
OXF and FBZSO2 at the predilection sites of the worms (i.e. mucosa
and digesta of caecum). However, by comparing our results with
those reported by Petersen (1998) transport pathways can be con-
sidered. Comparison is possible since the plasma concentrations in
this study are only slightly higher than reported by Petersen and
the fractions of FBZ, OXF and FBZSO2 were found to be similar
(Table 4). In this study the major drug compounds found in worms
after a single dose treatment were OXF and FBZSO2. From the
in vitro studies we know that only small fraction of FBZ is metab-
olised by T. suis and therefore, the high concentration of OXF and
FBZSO2 in the worms may originate from the host. According to
Petersen (1998) the major drug fraction in the content of caecum
is FBZ (75.7% and 85.7%) whereas OXF is the major fraction in
plasma (75.8% and 54.6%) (Table 4). Supported by the high correla-
tion between concentrations of OXF in plasma and worms (Fig. 1),
we suggest that OXF reaches the worms via the blood–enterocyte
pathway. FBZSO2 showed a similar distribution pattern as OXF,
as FBZSO2 amounted 19.2% in plasma and only 2.7% in the content
of the caecum, respectively. The high correlation between concen-
trations of FBZSO2 in worms and plasma (Fig. 1) further indicate
that these drug metabolites might reach the worm from the sys-
temic circulation. After a single dose treatment the concentration
of FBZ in worms was higher 24 h in comparison to 12 h p.t. Only
a minor proportion of FBZ was found in plasma (5.0%) whereas
high proportions were present at the predilection site (mucosa:
58.1%, content: 75.7%). Furthermore, no correlation was found
between FBZ concentrations in worms and plasma (Fig. 1). We
therefore suggest that the main fraction of FBZ, accumulating in
the worms originate from the intestinal digesta of the host
although someminor part may enter from the systemic circulation.
The World Association for the Advancement of Veterinary Para-
sitology (WAAVP) guidelines for evaluating the efﬁcacy of anthel-
mintic in swine recommend a period of 5–7 days after treatment
before worm count is performed (Hennessy et al., 2006). The pres-
ent work was not directed towards estimating the efﬁcacy of a tri-
ple dose regime with FBZ, but to obtain indicative information on
the treatment efﬁcacy which showed an immediate and very high
worm count reduction (98.5%) as early as 24 h after the last treat-
ment. The worms isolated from pigs in group 4 (24 h after repeated
FBZ treatments) were expected to be undergoing expulsion as they
were all isolated from the intestinal content of the colon, suggesting
an even higher reduction in worm count if post mortem wasconducted according to guidelines. This ﬁnding is in accordance
with previous studies whereWCR reported after 5 mg/kg FBZ given
for 3 consecutive days were 99.7% and 99.9% four to ﬁve days after
the last treatment day (Batte, 1978; Stewart et al., 1981). With the
relatively high concentration of OXF observed in the worms, the
high WCR and the low effect of FBZ observed in vitro (Hansen
et al., 2014) we speculate that OXF, as compared to FBZ, is the drug
compound with the highest availability, thus a higher efﬁcacy
against Trichuris spp. infections. Future in vitro studies comparing
FBZ and OXF are needed.
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